Azurity Pharmaceuticals, Inc.
Azurity Pharmaceuticals, Inc. lists 57 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 24338-160 | Arynta Solution | Lisdexamfetamine Dimesylate 10 mg/mL | Rx |
| 24338-162 | Arynta Solution | Lisdexamfetamine Dimesylate 10 mg/mL | Rx |
| 24338-109 | Arynta Solution | Lisdexamfetamine Dimesylate 10 mg/mL | Rx |
| 24338-103 | Arynta Solution | Lisdexamfetamine Dimesylate 10 mg/mL | Rx |
| 24338-019 | Arynta Solution | Lisdexamfetamine Dimesylate 10 mg/mL | Rx |
| 24338-055 | Azmiro Injection, Solution | Testosterone Cypionate 200 mg/mL | Rx |
| 24338-056 | Azmiro Injection, Solution | Testosterone Cypionate 200 mg/mL | Rx |
| 24338-010 | BiDil Tablet, Film Coated | Hydralazine Hydrochloride 37.5 mg/1; Isosorbide Dinitrate 20 mg/1 | Rx |
| 24338-017 | Brynovin Solution | Sitagliptin 25 mg/mL | Rx |
| 24338-154 | Danziten Tablet | Nilotinib 71 mg/1 | Rx |
| 24338-155 | Danziten Tablet | Nilotinib 95 mg/1 | Rx |
| 60631-040 | Edarbi Tablet | Azilsartan Kamedoxomil 40 mg/1 | Rx |
| 60631-080 | Edarbi Tablet | Azilsartan Kamedoxomil 80 mg/1 | Rx |
| 52652-4001 | Epaned Solution | Enalapril Maleate 1 mg/mL | Rx |
| 52652-9001 | Eprontia Solution | Topiramate 25 mg/mL | Rx |
| 24338-022 | Evekeo Tablet | Amphetamine Sulfate 5 mg/1 | Rx |
| 24338-026 | Evekeo Tablet | Amphetamine Sulfate 10 mg/1 | Rx |
| 24338-310 | FeraBright Injection | Ferumoxytol 30 mg/mL | Rx |
| 24338-510 | FeraBright Injection | Ferumoxytol 30 mg/mL | Rx |
| 65628-204 | Firvanq Kit | Rx | |
| 65628-205 | Firvanq Kit | Rx | |
| 65628-206 | Firvanq Kit | Rx | |
| 65628-208 | Firvanq Kit | Rx | |
| 52652-6001 | Fleqsuvy Suspension | Baclofen 5 mg/mL | Rx |
| 24338-340 | Gleostine Capsule, Gelatin Coated | Lomustine 10 mg/1 | Rx |
| 24338-341 | Gleostine Capsule, Gelatin Coated | Lomustine 40 mg/1 | Rx |
| 24338-342 | Gleostine Capsule, Gelatin Coated | Lomustine 100 mg/1 | Rx |
| 24338-050 | Gliadel Wafer | Carmustine 7.7 mg/1 | Rx |
| 24338-236 | GoLYTELY Powder, For Solution | Polyethylene Glycol 3350 236 g/4L; Sodium Sulfate Anhydrous 22.74 g/4L; Sodium… | Rx |
| 24338-119 | Ivermectin Lotion | Ivermectin 5 mg/g | OTC |
| 24338-115 | Javadin Solution | Clonidine Hydrochloride 20 ug/mL | Rx |
| 52652-5001 | Katerzia Suspension | Amlodipine Benzoate 1 mg/mL | Rx |
| 65628-272 | Konvomep Kit | Rx | |
| 24338-018 | Myhibbin Suspension | Mycophenolate Mofetil 200 mg/mL | Rx |
| 24338-230 | Nymalize Solution | Nimodipine 30 mg/5mL | Rx |
| 24338-260 | Nymalize Solution | Nimodipine 60 mg/10mL | Rx |
| 52652-3001 | Qbrelis Solution | Lisinopril 1 mg/mL | Rx |
| 24338-530 | Sotylize Solution | Sotalol Hydrochloride 5 mg/mL | Rx |
| 24338-550 | Suflave Kit | Rx | |
| 24338-177 | SUPREP Bowel Prep Solution, Concentrate | Sodium Sulfate 13.13 g/133.1mL; Potassium Sulfate 2.35 g/133.1mL; Magnesium Sulfate,… | Rx |
| 24338-175 | SUPREP Bowel Prep Solution, Concentrate | Sodium Sulfate 17.5 g/mL; Potassium Sulfate 3.13 g/mL; Magnesium Sulfate, Unspecified… | Rx |
| 24338-201 | Sutab Tablet | Sodium Sulfate 17.75 g/1; Magnesium Sulfate Anhydrous 2.7 g/1; Potassium Chloride 2.25 g/1 | Rx |
| 24338-150 | Triptodur Kit | Rx | |
| 24338-270 | Vivimusta Injection | Bendamustine Hydrochloride 25 mg/mL | Rx |
| 24338-001 | Widaplik Tablet | Telmisartan 10 mg/1; Amlodipine Besylate 1.25 mg/1; Indapamide .625 mg/1 | Rx |
| 24338-003 | Widaplik Tablet | Telmisartan 40 mg/1; Amlodipine Besylate 5 mg/1; Indapamide 2.5 mg/1 | Rx |
| 24338-002 | Widaplik Tablet | Telmisartan 20 mg/1; Amlodipine Besylate 2.5 mg/1; Indapamide 1.25 mg/1 | Rx |
| 52652-2001 | Xatmep Solution | Methotrexate 2.5 mg/mL | Rx |
| 24338-153 | Xifyrm Injection | Meloxicam 30 mg/mL | Rx |
| 24338-856 | Zenzedi Tablet | Dextroamphetamine Sulfate 30 mg/1 | Rx |
| 24338-855 | Zenzedi Tablet | Dextroamphetamine Sulfate 20 mg/1 | Rx |
| 24338-854 | Zenzedi Tablet | Dextroamphetamine Sulfate 15 mg/1 | Rx |
| 24338-853 | Zenzedi Tablet | Dextroamphetamine Sulfate 10 mg/1 | Rx |
| 24338-852 | Zenzedi Tablet | Dextroamphetamine Sulfate 7.5 mg/1 | Rx |
| 24338-851 | Zenzedi Tablet | Dextroamphetamine Sulfate 5 mg/1 | Rx |
| 24338-850 | Zenzedi Tablet | Dextroamphetamine Sulfate 2.5 mg/1 | Rx |
| 52652-8001 | Zonisade Suspension | Zonisamide 100 mg/5mL | Rx |
Recalls by Azurity Pharmaceuticals, Inc.
- D-0323-2024 Feb 7, 2024 · Class I
Labeling: Label Mix-up - D-0213-2024 Jan 10, 2024 · Class III
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months. - D-0489-2023 Apr 12, 2023 · Class II
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. - D-0003-2022 Oct 13, 2021 · Class I
Product Mix-up: Incorrect diluent component included in the kit.